Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 -0.97%77 PEG Ratio is 24.21 as of Jul. 16, 2026, which is 5% above its 10-year median of 22.98. GuruFocus rates TSE:9341 with a GF Score™ of 77/100 and a GF Value™ of 円1,961.82 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 209 Medical Devices & Instruments companies, Genova ranks worse than 96.65% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Genova's PE Ratio without NRI is 46.00. Genova's 5-Year EBITDA growth rate is 1.90%. Therefore, Genova's PEG Ratio for today is 24.21.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Genova's PEG Ratio or its related term are showing as below:
TSE:9341'
s PEG Ratio Range Over the Past 10 Years
Min: 21.98 Med: 22.98 Max: 24.69
Current: 24.21
During the past 6 years, Genova's highest PEG Ratio was 24.69. The lowest was 21.98. And the median was 22.98.
TSE:9341's PEG Ratio is ranked worse than 96.65% of 209
companies
in the Medical Devices & Instruments industry
Industry Median: 2.01
vs TSE:9341: 24.21
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Genova (TSE:9341) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Genova PEG Ratio Related Terms
Genova PEG Ratio Historical Data
* Premium members only.
The historical data trend for Genova's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Genova's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Genova's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Genova (TSE:9341) has a PEG Ratio of 24.21 as of Jul. 16, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Genova and its competitors. This is near median its historical median of 22.98. Over the past decade, Genova's PEG Ratio has ranged from 21.98 to 24.69. According to the industry distribution chart, Genova ranks #202 out of 209 companies in the Medical Devices & Instruments industry, placing it in the top 96.7%.
Is Genova's PEG Ratio too high?
Genova's current PEG Ratio of 24.21 is near median its 10-year median of 22.98. Over the past 10 years, this metric has ranged from a low of 21.98 to a high of 24.69. The Medical Devices & Instruments industry median PEG Ratio is 2.01. Genova's value of 24.21 is 1104.5% above this industry median. Based on the distribution chart, Genova ranks #202 out of 209 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Genova has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #202 out of 209 companies for PEG Ratio. This places Genova in the lower half of its industry. The industry median PEG Ratio is 2.01. Genova's value of 24.21 is 1104.5% above this benchmark. Historically, Genova's own PEG Ratio has ranged from 21.98 to 24.69 over the past decade. While the company's 10-year median is 22.98 vs. the industry median of 2.01, Genova has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.01, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genova's current PEG Ratio of 24.21 is 1104.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current PEG Ratio is 24.21, which is near median its own 10-year median of 22.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,961.82, compared to a current price of 円611.00 — trading 68.9% below its estimated fair value. The current PEG Ratio is 24.21, which is near median its 10-year median of 22.98 and 1104.5% above the Medical Devices & Instruments industry median of 2.01. Genova's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Genova (TSE:9341), the current PEG Ratio is 24.21 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円611.00 is trading 68.9% below its estimated GF Value™ of 円1,961.82.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
PEG Ratio: 24.21 (near median its 10-year median of 22.98)
GF Value™: 円1,961.82 vs. price of 円611.00 (68.9% below fair value)
Industry Position: 1104.5% above the Medical Devices & Instruments median (#202 of 209)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
77GF Score
Get the complete analysis for TSE:9341
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
